Presentation is loading. Please wait.

Presentation is loading. Please wait.

KCMC Case Presentation: A 20 year-old male with Altered Mental Status Jesse Waggoner Resident, Internal Medicine International Health Elective.

Similar presentations

Presentation on theme: "KCMC Case Presentation: A 20 year-old male with Altered Mental Status Jesse Waggoner Resident, Internal Medicine International Health Elective."— Presentation transcript:

1 KCMC Case Presentation: A 20 year-old male with Altered Mental Status Jesse Waggoner Resident, Internal Medicine International Health Elective

2 History of Present Illness 20 y/o male with no known past medical history Brought to ED by family for 1 month of malaise and worsening headache Recently, pt had become lethargic and slow to respond to questions at home Over the 3 days prior to admission, patient had been vomiting and became unresponsive No previous history of such episodes

3 Further History ROS: per family members report, no fevers, chills or night sweats; no diarrhea; no weight loss Social History: unknown sexual history, no known EtOH abuse or IVDU, worked as a farmer near Moshi Family History: no significant family medical history known

4 Physical Exam Vitals: / on 2L NC Gen: pt lying in bed, responds to pain, GCS 8 (eyes open, withdraws to pain) Neuro: CN: pupils 5mm, sluggish, corneal reflexes and gag in-tact Motor: bulk nml, tone decreased Reflexes: 2+ DTRs, toes downgoing HEENT: Fundi show papilledema, op clear Lungs: CTAB, no w/r/r, limited by pt cooperation CV: RRR, nl s1 and s2, no m/r/g Abd: soft, NTND, +bs, no HSM Ext: no c/c/e, 2+ peripheral pulses Skin: no rashes or lesions

5 Laboratory Data Chemistry: Cr 78 (0.9) Full Blood Picture: Hgb 4, WBC 0.6, Plts 25 Rapid HIV: negative x 2 Blood culture: no growth LP not obtained given results of funduscopic exam

6 Imaging CT brain (on admission): 3 cm ring enhancing lesion in the R parietal and occipital lobes with surrounding edema and mass effect No evidence of sinusitis or site for direct extension of infection Chest X-ray: No infiltrate, nml cardiac silhouette, no bony lesions

7 Differential Diagnosis Brain Abscess: no site for direct spread Tuberculoma Toxoplasmosis Primary CNS lymphoma

8 Clinical Course Pt initially treated with chloramphenicol and ampicillin without clinical deterioration Following results of CT, antibiotic coverage changed to ceftriaxone and metronidazole Pt continued to worsen clinically and 4 drug TB therapy (INH, RIF, PZA, EMB) was added along with prednisolone 60 mg/day Over the following week, pt became more alert per family members report Neurosurgery consulted and felt patient was a poor candidate for surgery

9 Diagnosis Final diagnosis remains unclear – pt did appear to respond to therapy for TB, though this included high dose steroids Etiology of pancytopenia is also unknown and leukopenia would have predisposed him to opportunistic pathogens not covered in the treatment regimen His clinical stability and advanced stage at presentation combined with available diagnostic tests limited our ability to make a definitive diagnosis

10 Discussion Brain abscess Microbiology Diagnosis CNS Tuberculosis Meningitis and Tuberculomas Treatment

11 Brain Abscess Can result from direct spread (sinusitis, otitis, neurosurgical procedure) or from hematogenous spread (more often multiple abscesses) Most common location for hematogenous spread: frontal or temporal lobes, frontal- parietal, or parietal Typically results from a bacterial infection, though in immunocompromised hosts, causes include fungi and other opportunistic pathogens

12 Microbiology of Brain Abscesses Anaerobes Anaerbic streptococci Bacteroides fragilis Prevotella melaninogenica Propionibacterium Fusobacterium Eubacterium Veillonella Actinomycetes Aerobes Viridans Strep Strep milleri Pneumococcus (rare) Staph aureus Klebsiella pneumoniae Psudomonas Eschericia coli Proteus

13 Microbiology of Brain Abscesses in Specific Hosts Immunocompromised Toxoplasma Rhodococcus equi Listeria Nocardia Mycobacteria Aspergillus Cryptococcus Coccidioides Candida Zygomycosis Travelers/Immigrants Cysticercosis Entamoeba Schistosoma japonicum Paragonimus

14 Brain Abscess (continued) Pts often present with worsening unilateral headache Changes in mental status develops with worsening cerebral edema and portends a poor prognosis Exam: fever only present in 50% of cases; focal neurological deficits develop after the headache Imaging: MRI more sensitive than CT and can differentiate abscess from neoplastic lesions Diagnosis often comes after guided aspiration or surgery

15 CNS Tuberculosis Three clinical manifestations: Meningitis Tuberculoma Spinal arachnoiditis Small tubercules (Rich foci) form during bacteremia following primary or reactivation disease These can form in the brain or meninges Development of meningitis or tuberculoma results from progression and possible rupture of these lesions

16 Epidemiology of CNS Tb Around 1% of Tb cases will develop CNS Tb (6.3% of extrapulm cases) Signs of Tb outside the CNS are only present in ~50% of cases In adults, risk factors for developing CNS Tb include: alcoholism, malignancy, immunosuppressive agents, & HIV

17 Tuberculoma Can present as single or multiple ring- enhancing lesions Usually present as a mass lesion but can occur in the setting of Tb meningitis (after one ruptures into the subarachnoid space) More common in developing countries than in the United States Tb brain abscess is a rare complication – do not see classic granulomas on pathology

18 Diagnosis CSF classically shows lymphocytic pleocytosis, elevated protein, & hypoglycorrachia in Tb meningitis Micro: CSF AFB smears: sensitivity 20-35% for one sample, up to 85% with consecutive samples Culture: sensitivity 71% No nucleic acid amplification tests currently approved in US for detection of Tb in CSF ADA in the CSF cannot reliably distinguish Tb meningitis from bacterial meningitis; also no standard cutoffs Contrasted MRI more sensitive for findings of CNS Tb than CT Basal meningeal enhancement Hydrocephalus Supratentorial infarctions

19 Treatment No RCTs have been performed to show the optimal drug regimen, dosage and duration of therapy Current guidelines recommend initial 4 drug therapy for 2 months followed by 7-10 months of continued 2 drug therapy INH: good CNS penetration RIF: penetrates inflamed meninges PZA: good CNS penetration EBM: lower CSF concentrations Glucocorticoids: shown to benefit adults in one RCT, particularly those with less severe disease (study used dexamethasone)

20 References 1. Kent SJ et al. Tuberculous meningitis: a 30-year review. Clin Infect Dis, 1993; 17: Kumar R et al. Tuberculous brain abscess: clinical presentation, pathophysiology, and treatment (in children). Childs Nerv Syst, 2002; 18: Leonard, J. Central nervous system tuberculosis. UpToDate, acessed 5/20/ Pai et al. Diagnostic accuracy of nucleic acid amplification tests for tuberculous meningitis: a systematic review and meta-analysis. Lancet Infect Dis, 2003; 3: Rock RB et al. Central nervous system tuberculosis: pathogenesis and clinical aspects. Clin Micro Rev, 2008; 21: Seydoux C et al. Bacterial brain abscesses: factors influencing mortality and sequelae. Clin Infect Dis, 1992; 15: Southwick FS. Pathogenesis, clinical manifestations, and diagnosis of brain abscess. UpToDate, accessed 5/20/ Tattevin P et al. Bacterial brain abscesses: a retrospective study of 94 patients admitted to an intensive care unit (1980 to 1999). Am J Med, 2003; 115: Thwaites GE et al. Dexamethasone for the treatment of tuberculous meningitis in adolescents and adults. NEJM, 2004; 351: Thwaites GE et al. Improving the bacteriological diagnosis of tuberculous meningitis. J Clin Micro, 2004; 42: Thwaites GE et al. Effect of antituberculosis drug resistance on response to treatment and outcome in adults with tuberculous meningitis. J Infect Dis, 2005; 192: 79-88

Download ppt "KCMC Case Presentation: A 20 year-old male with Altered Mental Status Jesse Waggoner Resident, Internal Medicine International Health Elective."

Similar presentations

Ads by Google